MYC and cancer: For instance, an hPRPS2 knockout in experimental models has resulted in c-Myc-driven tumorigenesis [52,53], suggesting that hPRPS2 may be a target protein for manipulating cancer cells, whereas it has been reported that a decrease in hPRPS1 expression impairs the proliferation of tumour cells [54].